121 related articles for article (PubMed ID: 8249047)
1. Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxide.
Gidal BE; Anderson GD; Seaton TL; Miyoshi HR; Wilenksy AJ
Ther Drug Monit; 1993 Oct; 15(5):405-9. PubMed ID: 8249047
[TBL] [Abstract][Full Text] [Related]
2. Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine.
Bu HZ; Kang P; Deese AJ; Zhao P; Pool WF
Drug Metab Dispos; 2005 Dec; 33(12):1920-4. PubMed ID: 16204461
[TBL] [Abstract][Full Text] [Related]
3. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
Svinarov DA; Pippenger CE
Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
5. Effect of Sophora flavescens on the pharmacokinetics of carbamazepine in rats.
Shi L; Dang XL; Liu XY; Wei HM; Yang MM; Zhang Y
Arch Pharm Res; 2014 Dec; 37(12):1617-23. PubMed ID: 24691829
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine and carbamazepine-10,11-epoxide clearance measurements during continuous venovenous hemofiltration in a massive overdose.
Smollin CG; Petrie MS; Kearney T
Clin Toxicol (Phila); 2016 Jun; 54(5):424-7. PubMed ID: 26942940
[TBL] [Abstract][Full Text] [Related]
7. Carbamazepine dose requirements during stiripentol therapy: influence of cytochrome P-450 inhibition by stiripentol.
Kerr BM; Martinez-Lage JM; Viteri C; Tor J; Eddy AC; Levy RH
Epilepsia; 1991; 32(2):267-74. PubMed ID: 2004631
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography.
Shimoyama R; Ohkubo T; Sugawara K
Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():210-5. PubMed ID: 10735366
[TBL] [Abstract][Full Text] [Related]
9. Potential interaction between carbamazepine and loxapine: case report and retrospective review.
Collins DM; Gidal BE; Pitterle ME
Ann Pharmacother; 1993 Oct; 27(10):1180-7. PubMed ID: 8251682
[TBL] [Abstract][Full Text] [Related]
10. Relative proportions of serum carbamazepine and its pharmacologically active 10,11-epoxy derivative: effect of polytherapy and renal insufficiency.
Tutor-Crespo MJ; Hermida J; Tutor JC
Ups J Med Sci; 2008; 113(2):171-80. PubMed ID: 18509811
[TBL] [Abstract][Full Text] [Related]
11. A new herb-drug interaction of Polygonum cuspidatum, a resveratrol-rich nutraceutical, with carbamazepine in rats.
Chi YC; Lin SP; Hou YC
Toxicol Appl Pharmacol; 2012 Sep; 263(3):315-22. PubMed ID: 22813711
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
Svinarov DA; Pippenger CE
Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine and its major metabolites in plasma: a summary of eight years of therapeutic drug monitoring.
Hundt HK; Aucamp AK; Müller FO; Potgieter MA
Ther Drug Monit; 1983; 5(4):427-35. PubMed ID: 6659015
[TBL] [Abstract][Full Text] [Related]
14. Protein binding of carbamazepine and its epoxide in maternal and fetal plasma at delivery: comparison to other anticonvulsants.
Kuhnz W; Steldinger R; Nau H
Dev Pharmacol Ther; 1984; 7(1):61-72. PubMed ID: 6697871
[TBL] [Abstract][Full Text] [Related]
15. Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry.
Bu HZ; Zhao P; Dalvie DK; Pool WF
Rapid Commun Mass Spectrom; 2007; 21(20):3317-22. PubMed ID: 17879390
[TBL] [Abstract][Full Text] [Related]
16. Reduced Systemic and Brain Exposure with Inhibited Liver Metabolism of Carbamazepine After Its Long-Term Combination Treatment with Piperine for Epilepsy Control in Rats.
Ren T; Xiao M; Yang M; Zhao J; Zhang Y; Hu M; Cheng Y; Xu H; Zhang C; Yan X; Zuo Z
AAPS J; 2019 Jul; 21(5):90. PubMed ID: 31321577
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine/valproic acid interaction in man and rhesus monkey.
Levy RH; Moreland TA; Morselli PL; Guyot M; Brachet-Liermain A; Loiseau P
Epilepsia; 1984 Jun; 25(3):338-45. PubMed ID: 6426944
[TBL] [Abstract][Full Text] [Related]
18. Effect of lamotrigine on carbamazepine epoxide/carbamazepine serum concentration ratios in adult patients with epilepsy.
Gidal BE; Rutecki P; Shaw R; Maly MM; Collins DM; Pitterle ME
Epilepsy Res; 1997 Oct; 28(3):207-11. PubMed ID: 9332885
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats.
Bedada SK; Neerati P
Naunyn Schmiedebergs Arch Pharmacol; 2018 Feb; 391(2):115-121. PubMed ID: 29134244
[TBL] [Abstract][Full Text] [Related]
20. The effect of cannabidiol on the pharmacokinetics of carbamazepine in rats.
Darweesh RS; Khamis TN; El-Elimat T
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1871-1886. PubMed ID: 32424477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
